Legend Biotech (LEGN) Construction in Progress (2019 - 2020)
Legend Biotech's (LEGN) quarterly Construction in Progress came in at $33.6 million in Q4 2020, up 1082.74% YoY from $2.8 million in Q1 2020, and up 1082.74% on a QoQ basis from $2.8 million in Q4 2019.
Powered by 
Analysis
Legend Biotech (LEGN) Construction in Progress (2019 - 2020) Analysis & Trends
Legend Biotech (LEGN) has 2 years of Construction in Progress data on file, last reported at $33.6 million in Q4 2020.
- Quarterly Construction in Progress rose 1082.74% year-over-year to $33.6 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $33.6 million (up 1082.74% YoY) and the FY2020 annual result came in at $33.6 million, up 1082.74% from the prior year.
- Construction in Progress climbed to $33.6 million in Q4 2020, from $2.8 million in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $33.6 million in Q4 2020 to a low of $2.8 million in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 152.67 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | - |